Isabelle Petit-Hartlein

Mrs. Isabelle Petit-Hartlein


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
AVAnnelise Vermot
Annelise Vermot
IPIsabelle Petit-Hartlein
Isabelle Petit-Hartlein
SSSusan M. E. Smith
Susan M. E. Smith
FFFranck Fieschi
Franck Fieschi
The reactive oxygen species (ROS)-producing enzyme NADPH oxidase (NOX) was first identified in the membrane of phagocytic cells. For many years, its only known role was in immune defense, where its ROS production leads to the destruction of pathogens by the immune cells. NOX from phagocytes catalyzes, via one-electron trans-membrane transfer to molecular oxygen, the production of the superoxide anion. Over the years, six human homologs of the catalytic subunit of the phagocyte NADPH oxidase were found: NOX1, NOX3, NOX4, NOX5, DUOX1, and DUOX2. Together with the NOX2/gp91phox component present in the phagocyte NADPH oxidase assembly itself, the homologs are now referred to as the NOX family of NADPH oxidases. NOX are complex multidomain proteins with varying requirements for assembly with combinations of other proteins for activity. The recent structural insights acquired on both prokaryotic and eukaryotic NOX open new perspectives for the understanding of the molecular mechanisms inherent to NOX regulation and ROS production (superoxide or hydrogen peroxide). This new structural information will certainly inform new investigations of human disease. As specialized ROS producers, NOX enzymes participate in numerous crucial physiological processes, including host defense, the post-translational processing of proteins, cellular signaling, regulation of gene expression, and cell differentiation. These diversities of physiological context will be discussed in this review. We also discuss NOX misregulation, which can contribute to a wide range of severe pathologies, such as atherosclerosis, hypertension, diabetic nephropathy, lung fibrosis, cancer, or neurodegenerative diseases, giving this family of membrane proteins a strong therapeutic interest.

27 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
PRPerrine Rochas
Perrine Rochas
MVMaria Val-Pevida
Maria Val-Pevida
SBSylvain Beaumel
Sylvain Beaumel
IPIsabelle Petit-Hartlein
Isabelle Petit-Hartlein
CPCaroline Plazy
Caroline Plazy
MSMarie Jose STASIA
Marie Jose STASIA
Recent advances in the structural characterization of the phagocyte NADPH oxidase coupled to the description of its chaperone EROS for Essential for Reactive Oxygen Species have led to a better understanding of its function and activation in phagocytic cells. This review examines the role of EROS chaperone in cytochrome b558 biosynthesis and function, in physiological and pathological conditions. Based on experimental data and structural insights, we synthesize knowledge from former work on cytochrome b558 synthesis and structure combined with recent advances on the specific role of EROS chaperone on the potential control of Reactive Oxygen Species (ROS) production by cytochrome b558. We particularly emphasize its role in the pathological context of Chronic Granulomatous Disease (CGD), with already described EROS mutations (known as CGD5), as well as rare Xminus-CGD cases characterized by low cytochrome b558 expression in phagocytes that could be due to a lack of interaction with EROS. Future works should address in more details how EROS binding and release from cytochrome b558 is regulated, and whether the inhibitory effect on ROS production that was observed in EROS overexpression studies is relevant in a more physiological context.

6 June 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
PRPerrine Rochas
Perrine Rochas
MVMaria Val-Pevida
Maria Val-Pevida
SBSylvain Beaumel
Sylvain Beaumel
IPIsabelle Petit-Hartlein
Isabelle Petit-Hartlein
CPCaroline Plazy
Caroline Plazy
MSMarie Jose STASIA
Marie Jose STASIA
Recent advances in the structural characterization of the phagocyte NADPH oxidase coupled with the description of its chaperone EROS for Essential for Reactive Oxygen Species have led to a better understanding of its function and activation in phagocytic cells. This review examines the role of EROS chaperone in flavocytochrome b558 biosynthesis and function and in physiological and pathological conditions. Based on experimental data and structural insights, we synthesize knowledge from former work on flavocytochrome b558 synthesis and structure combined with recent advances on the specific role of EROS chaperone on the potential control of Reactive Oxygen Species (ROS) production by c flavocytochrome b558. We particularly emphasize its role in the pathological context of Chronic Granulomatous Disease (CGD), with already described EROS mutations (known as CGD5), as well as rare X91minus-CGD (or X91−-CGD) cases characterized by low flavocytochrome b558 expression in phagocytes that could be due to a lack of interaction with EROS. Future works should address in more detail how EROS binding and release from flavocytochrome b558 is regulated, and whether the inhibitory effect on ROS production that was observed in EROS overexpression studies is relevant in a more physiological context.